Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2027

Building a National Security Healthcare company focused on dual-use medical technologiesHalifax, Nova Scotia--(. - November 12, 2026) - Appili Therapeutics Inc. (NEX: APLI.H) (OTC Pink: APLIF) (the "Company" or "Appili"), a biopharmaceutical company building a National Security Healthc…